Teriparatide (Forteo) is a synthetic version of the human parathyroid hormone, which helps to regulate calcium metabolism. It promotes the growth of new bone, while other osteoporosis medications improve bone density by inhibiting bone resorption, or breakdown. It is the only osteoporosis medicine approved by the FDA that rebuilds bone.
Forteo should be used only in men with osteoporosis and postmenopausal women.
Reality:Osteoporosis and bone disease often result in painful and debilitating fractures. These injuries can have significant long-term consequences, leaving the individuals with chronic pain, loss of height, and impaired ability to do the things they need to do to care for themselves, such as dress, bathe, walk, and take care of their household.
Many osteoporosis fractures -- about 300,000 every year -- are hip fractures, which are particularly dangerous and debilitating. One in four hip fracture...
Teriparatide (Forteo) is self-injected into the skin. Because long-term safety is not yet established, it is only FDA-approved for 24 months of use. It reduces spine fractures in women with known osteoporosis, but reduction of hip fracture risk is currently unproven.
Who Should Take Forteo?
Men who have osteoporosis and postmenopausal women can take Forteo.
Forteo is not used to prevent osteoporosis or to treat mild osteoporosis.
This drug should be used if you've had at least one bone fracture due to thinning bones, you are at high risk of fractures, or you haven't responded to other osteoporosis therapies.